financetom
Business
financetom
/
Business
/
PGIM Fixed Income completes private purchase of $500 mln loan from Affirm
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PGIM Fixed Income completes private purchase of $500 mln loan from Affirm
Dec 3, 2024 6:26 AM

NEW YORK, Dec 3 (Reuters) - Prudential Financial's ( PRU )

PGIM Fixed Income has completed the private purchase of

$500 million worth of loans from buy-now-pay-later firm Affirm

Holdings ( AFRM ), the two companies said on Tuesday.

The transaction deepens Affirm's partnership with PGIM Fixed

Income, which manages an asset-based finance business with more

than $120 billion in assets under management across public and

private securitized credit

PGIM Fixed Income had also invested in Affirm's assets in

the past through asset-backed securitizations, the statement

said.

PGIM Fixed Income has originated multiple billions of

dollars of asset-backed financing this year and expects to

nearly triple the amount next year, Edwin Wilches, Managing

Director and Co-Head of Securitized Products at PGIM Fixed

Income, told Reuters.

"The economy is growing, need for financing is growing and

the traditional lender banks have less appetite or have less

ability to do (these kinds of financing). So there's a gap," he

said.

Other factors that are helping to grow the ABF market for

fund managers is more flows into fixed income markets as yields

are higher, insurance companies are growing and diversifying,

while additional demand is coming from pensions.

"We see U.S. pension funds being attracted to ABF deals as

they provide attractive spreads while achieving a

diversification benefit away from their pre-existing public and

private corporate-focused portfolios," Wilches said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kaspi.kz's Q4 Net Income, Revenue Increase
Kaspi.kz's Q4 Net Income, Revenue Increase
Feb 24, 2025
07:34 AM EST, 02/24/2025 (MT Newswires) -- Kaspi.kz (KSPI) reported Q4 net income Monday of 316.40 billion Kazakhstani tenge ($628.6 million), up from 247.99 billion Kazakhstani tenge a year earlier. Four analysts polled by FactSet expected 323.25 billion Kazakhstani tenge. Revenue for the quarter ended Dec. 31 was 730.35 billion Kazakhstani tenge, up from 570.79 billion Kazakhstani tenge a year...
Top Premarket Gainers
Top Premarket Gainers
Feb 24, 2025
07:37 AM EST, 02/24/2025 (MT Newswires) -- AtlasClear Holdings ( ATCH ) shares more than doubled pre-bell Monday following a 1.7% loss in the previous session. Oriental Rise ( ORIS ) stock was 64% higher after Friday's 1.8% gain. ISpecimen ( ISPC ) shares were up 36% after a 3.9% fall on Friday. VirnetX Holding ( VHC ) stock was...
QIA evaluating eight new VC firms for inclusion in $1 billion 'Fund of Funds'
QIA evaluating eight new VC firms for inclusion in $1 billion 'Fund of Funds'
Feb 24, 2025
DOHA (Reuters) - Qatar's sovereign wealth fund is evaluating eight venture capital firms to add to its fund of funds venture capital programme, which has already invested nearly $500 million in six firms, the head of funds at the Qatar Investment Authority (QIA) told Reuters on Monday. The $1 billion programme will be almost fully invested if all eight additional...
Entrada Therapeutics Says FDA Lifted Clinical Hold on ENTR-601-44; Shares Advance Premarket
Entrada Therapeutics Says FDA Lifted Clinical Hold on ENTR-601-44; Shares Advance Premarket
Feb 24, 2025
07:43 AM EST, 02/24/2025 (MT Newswires) -- Entrada Therapeutics ( TRDA ) said Monday that the US Food and Drug Administration has lifted the clinical hold on ENTR-601-44 and cleared the company's plan to start a phase 1b study of the product candidate as a potential treatment for adults with Duchenne muscular dystrophy or DMD. The company said the 1b...
Copyright 2023-2026 - www.financetom.com All Rights Reserved